Mariner
AKBA icon

Mariner’s Akebia Therapeutics AKBA Stock Holding History

Mariner’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Buy
+154,256
New +$184K ﹤0.01% 3197
2025
Q4 		– Sell
-27,243
Closed -$74.4K – 3535
2025
Q3 		$74.4K Sell
27,243
-11,083
-29% -$36.9K ﹤0.01% 3403
2025
Q2 		$140K Buy
38,326
+557
+1% +$1.53K ﹤0.01% 3165
2025
Q1 		$72.5K Buy
37,769
+22,825
+153% +$46.6K ﹤0.01% 3249
2024
Q4 		$28.4K Buy
+14,944
New +$25.9K ﹤0.01% 3335

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mariner's AKBA Position: Q2 2026 in Review

Mariner opened a new position in Akebia Therapeutics (AKBA) in Q2 2026: 154,256 shares worth $176K. The stake represents ﹤0.01% of the portfolio and ranks #3197 among its holdings. This is a return to the name: Mariner previously reported a position in AKBA as recently as Q3 2025.

Mariner first reported a position in AKBA in Q4 2024 and has held it in 5 quarters since. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Mariner held 154,256 shares of Akebia Therapeutics worth $176K as of Q2 2026.
  • Akebia Therapeutics was a new Mariner position in Q2 2026.
  • Akebia Therapeutics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3197 holding.
  • Mariner first reported a position in Akebia Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.